Herbs (Global Traditional) · Ayurveda
Crotalaria juncea
Preliminary Evidencebotanical
Hermetica Superfood Encyclopedia
Crotalaria juncea is an Ayurvedic plant containing bioactive compounds that demonstrate antimicrobial activity against Gram-positive bacteria with MIC values of 16-200 μg/mL. The extract shows anti-inflammatory potential through 76.31% lipoxygenase enzyme inhibition comparable to indomethacin.
Crotalaria juncea L., commonly known as sunn hemp, is a tropical annual leguminous plant native to the Indian subcontinent and widely cultivated in tropical and subtropical regions. The plant belongs to the Fabaceae family and is typically processed using ethanol extraction methods from its stems, leaves, roots, flowers, and seeds for bioactive compound isolation.
No human clinical trials, randomized controlled trials (RCTs), or meta-analyses have been conducted with Crotalaria juncea. Research is limited to in vitro antimicrobial assays and cytotoxicity tests (PMID: 38213478 for flower extract antimicrobials), with all existing studies being preclinical laboratory investigations only.
No clinically studied dosage ranges exist as human trials are absent. In vitro studies used ethanolic extracts at 1-500 μg/mL for antimicrobial testing, with non-toxic effects observed up to 100-300 μg/mL in cell culture. No standardization or human dosing guidelines have been established. Consult a healthcare provider before starting any new supplement.
Crotalaria juncea (sunn hemp) seeds and leaves contain notable bioactive compounds and nutrients. **Proteins:** Seeds contain approximately 30-35% crude protein, making it a significant plant protein source, though anti-nutritional factors (pyrrolizidine alkaloids) limit direct consumption. **Fiber:** High dietary fiber content (~30-40% in seed hulls), primarily cellulose and hemicellulose. **Minerals:** Contains calcium (~0.3-0.5% dry weight), phosphorus (~0.2-0.4%), potassium (~1.0-1.5%), iron (~50-150 mg/kg), magnesium, and zinc in moderate amounts. **Bioactive compounds:** Rich in flavonoids including vitexin, isovitexin, and orientin (concentrations ~0.5-2.0 mg/g dry weight); phenolic acids including gallic acid, caffeic acid, and chlorogenic acid (total phenolics ~15-45 mg GAE/g extract). **Pyrrolizidine alkaloids (PAs):** Contains monocrotaline (primary PA, ~0.5-3.0% in seeds), retronecine-type alkaloids including junceine and crotananine — these are hepatotoxic and limit internal medicinal use; seeds are considered toxic for ingestion in significant quantities. **Fatty acids:** Seed oil (~5-8% content) contains linoleic acid (~45-55%), oleic acid (~20-30%), and palmitic acid (~10-15%). **Vitamins:** Leaves contain moderate vitamin C (~20-40 mg/100g fresh weight), beta-carotene (~2-5 mg/100g fresh leaves), and B-complex vitamins in trace amounts. **Saponins and tannins:** Present in moderate quantities (~2-5% dry weight), contributing to antimicrobial properties. **Bioavailability notes:** Pyrrolizidine alkaloids are readily bioavailable and hepatotoxic upon metabolic activation via cytochrome P450 enzymes; flavonoid glycosides (vitexin, orientin) have relatively low oral bioavailability (~5-10%) due to poor intestinal absorption. Phenolic compounds show moderate bioavailability enhanced by traditional aqueous/alcoholic extraction methods used in Ayurvedic preparations. External (topical) applications bypass PA hepatotoxicity concerns, improving therapeutic safety index for antimicrobial and anti-inflammatory uses.
Crotalaria juncea exerts anti-inflammatory effects by inhibiting lipoxygenase (LOX) enzymes, which are responsible for producing inflammatory mediators like leukotrienes. The antimicrobial activity appears to target bacterial cell wall synthesis or membrane integrity in Gram-positive bacteria. The bioactive compounds also demonstrate antifungal properties against dermatophyte species like Microsporum gypseum.
Current evidence for Crotalaria juncea is limited to preliminary in vitro studies only. Laboratory research shows antimicrobial activity with minimum inhibitory concentrations ranging from 16-200 μg/mL against various Gram-positive bacteria and 200 μg/mL against Microsporum gypseum fungi. Anti-inflammatory testing demonstrates 76.31% lipoxygenase inhibition comparable to the pharmaceutical drug indomethacin. No human clinical trials or animal studies have been conducted to validate these preliminary findings.
Safety data for Crotalaria juncea is extremely limited with no established human safety profile or dosage guidelines. Many Crotalaria species contain pyrrolizidine alkaloids which can cause severe hepatotoxicity and should be avoided during pregnancy and breastfeeding. Potential interactions with anti-inflammatory medications like NSAIDs are unknown but theoretically possible given the LOX inhibition activity. Consultation with healthcare providers is essential before use, especially for individuals with liver conditions or those taking medications.
